XBiotech, the developer of True Human therapeutic antibodies, has named Kelly Thornburg as senior vice president of operations. Mr. Thornburg brings more than 30 years of pharmaceutical operations experience to XBiotech, the prior 16 years spent at Amgen. Mr. Thornburg will oversee manufacturing operations for the production of the company’s True Human therapeutic antibodies. Among his duties, he will oversee the transition from Phase 3 clinical manufacturing to launch of commercial pro...